首页 | 本学科首页   官方微博 | 高级检索  
检索        

接种新型冠状病毒肺炎疫苗后出现1例过敏性休克的调查处置
引用本文:李映霞,谭文艳,李成华,李剑雄.接种新型冠状病毒肺炎疫苗后出现1例过敏性休克的调查处置[J].上海预防医学,2022,34(12):1188-1191.
作者姓名:李映霞  谭文艳  李成华  李剑雄
作者单位:1.长沙市疾病预防控制中心, 湖南 长沙 410004
摘    要:过敏性休克属于严重、罕见的不良反应,如不及时处理,常可危及生命。新型冠状病毒肺炎(简称“新冠病毒”)疫苗为新上市疫苗,人们对其不良反应的关注度高。本文分析1例接种新冠病毒疫苗后发生过敏性休克案例的调查处置过程,为规范接种疫苗后过敏性休克的诊断处理提供参考。

关 键 词:过敏性休克    新型冠状病毒肺炎疫苗    调查    处置
收稿时间:2022-04-18

Investigation and management of an anaphylactic shock case after inoculation with COVID-19 vaccine
Abstract:Anaphylactic shock is a serious and rare adverse reaction, which can be life-threatening if not treated in time. COVID-19 vaccine is a newly marketed vaccine, and people pay high attention to its adverse reactions. This report summarized the investigation and management process of a case of anaphylactic shock after inoculation with COVID-19 vaccine, in order to provide reference for standardizing the diagnosis and management of anaphylactic shock after vaccination.
Keywords:
点击此处可从《上海预防医学》浏览原始摘要信息
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号